Europe Bioinformatics Market - Industry Trends Forecast to 2029
- Published Date: 2022-12-22
- Report ID: 143118
- Pages: 225
-
Format:
Short Description:
Europe bioinformatics market, By Type (Knowledge management tools (generalized knowledge management tools, specialized knowledge management tools), Bioinformatics software (informatics infrastructure and pipeline setup, sample and experiment management, sequencing data analysis (sequence analysis platform, sequence alignment platform, sequence manipulation platform, structural analysis platform)) Biological data interpretation, specialized bioinformatics application (single cell gene expression, gene expression, variant detection, CNV analysis, metagenomics, methylation, chip-seq, non-coding RNA expression and others), Services), Sector (medical biotechnology, academics, animal biotechnology, agricultural biotechnology, environmental biotechnology, forensic biotechnology and others), Application( Genomics & Drug Development (knowledge management tools, bioinformatics software, services, type(preventive medicine, molecular medicine, personalized medicine, chemo-informatics and drug design, antibiotic resistance) Proteomics (knowledge management tools, bioinformatics software, services), Evolutionary studies (knowledge management tools, bioinformatics software, services), Agricultural studies(knowledge management tools, bioinformatics software, services), Veterinary Science (knowledge management tools, bioinformatics software, services), Metabolomics (knowledge management tools, bioinformatics software, services), Transcriptomics(knowledge management tools, bioinformatics software, services) and others (knowledge management tools, bioinformatics software, services), Purchase mode (group purchase and individual purchase), Genomics (Genomics (DNA and RNA), Proteomics) End User (Research and academic institute, Clinical research organization, biotech and pharmaceutical companies, research laboratories, hospitals and Others.) Country (Germany, France, U.K., Italy, Russia, Spain, Switzerland, Netherlands, Belgium, Turkey, and Rest of Europe) Industry Trends & Forecast to 2029.
Market Definition:
Bioinformatics, which is connected to genetics and genomics, uses computer technology to gather, store, analyze, and share biological data and information, such as DNA and amino acid sequences or annotations about those sequences. The three components of bioinformatics are building databases, creating statistics and algorithms, data analysis, and interpretation. Identification of genes and proteins, as well as their functions, evolutionary relationships, and conformation prediction, are the main goals.
For instance,
In 2021, Agilent unveiled Sure-Select Human All Exon V8, a novel exome design that offers thorough content and current coverage of protein-coding areas from RefSeq, CCDS, and GENCODE. Additionally, it includes exons that are challenging to capture and the TERT promoter, which are neglected by competing exomes.
The drivers responsible for the growth of the Europe bioinformatics market are increased prevalence of use of bioinformatics equipment, decrease in the cost of genetic sequencing per base, technological advancements in the bioinformatics devices, and wide product portfolio offered by major players. However, the rise in the cost of devices, risks observed while using the devices, difficulty in using bioinformatics devices, and cybersecurity concerns in bioinformatics is expected to restrain the market growth.
On the other hand, strategic initiatives by key players, a rise in healthcare expenditure, and an increase in research and development activities may act as an opportunity for the growth of the global bioinformatics market. However, the need for skilled expertise and regulatory approval may create challenges for the global bioinformatics market.
Market Segmentation:
The Europe bioinformatics market is categorized into six segments: type, sector, application, purchase mode, genomics, and end user.
On the basis of type, the Europe bioinformatics market is segmented into Knowledge management tools (generalized knowledge management tools, specialized knowledge management tools), Bioinformatics software (informatics infrastructure and pipeline setup, sample and experiment management, sequencing data analysis (sequence analysis platform, sequence alignment platform, sequence manipulation platform, structural analysis platform) Biological data interpretation, specialized bioinformatics application (single-cell gene expression, gene expression, variant detection, CNV analysis, metagenomics, methylation, chip-seq, non-coding RNA expression, and others), Services)
On the basis of sector, the Europe bioinformatics market is segmented into medical biotechnology, academics, animal biotechnology, agricultural biotechnology, environmental biotechnology, forensic biotechnology, and others.
On the basis of application, Genomics & Drug Development (knowledge management tools, bioinformatics software, services, by type(preventive medicine, molecular medicine, personalized medicine, chemo-informatics, and drug design, antibiotic resistance) Proteomics (knowledge management tools, bioinformatics software, services), Evolutionary studies (knowledge management tools, bioinformatics software, services), Agricultural studies(knowledge management tools, bioinformatics software, services), Veterinary Science (knowledge management tools, bioinformatics software, services), Metabolomics (knowledge management tools, bioinformatics software, services), Transcriptomics(knowledge management tools, bioinformatics software, services) and others (knowledge management tools, bioinformatics software, services).
On the basis of purchase mode, the Europe bioinformatics market is segmented into group purchases and individual purchases.
On the basis of genomics, the Europe bioinformatics market is segmented into Genomics (DNA and RNA) and Proteomics.
On the basis of end-user, the Europe bioinformatics market is segmented into Research and academic institute, Clinical research organizations, biotech and pharmaceutical companies, research laboratories, hospitals, and others.
Market Players:
The key market players operating in the Europe bioinformatics market are listed below:
Thermo Fisher Scientific
Illumina, Inc
Agilent Technologies, Inc
QIAGEN
SOPHiA GENETICS
BGI
Bayer AG
DNANEXUS, INC
PerkinElmer Inc.
Seven Bridges Genomics
Quest Diagnostics Incorporated
AstridBio Technologies Inc
BioBam
Strand Life Sciences
GenoFAB, Inc
TABLE OF CONTENTS
1 INTRODUCTION 26
1.1 OBJECTIVES OF THE STUDY 26
1.2 MARKET DEFINITION 26
1.3 OVERVIEW OF THE EUROPE BIOINFORMATICS MARKET 26
1.4 CURRENCY AND PRICING 29
1.5 LIMITATION 29
1.6 MARKETS COVERED 29
2 MARKET SEGMENTATION 33
2.1 MARKETS COVERED 33
2.2 GEOGRAPHIC SCOPE 34
2.3 YEARS CONSIDERED FOR THE STUDY 35
2.4 CURRENCY AND PRICING 35
2.5 RESEARCH METHODOLOGY 36
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 39
2.7 MULTIVARIATE MODELLING 40
2.8 TYPE SEGMENT LIFELINE CURVE 40
2.9 DBMR MARKET POSITION GRID 41
2.10 VENDOR SHARE ANALYSIS 43
2.11 MARKET APPLICATION COVERAGE GRID 44
2.12 THE CATEGORY VS TIME GRID 45
2.13 SECONDARY SOURCES 46
2.14 ASSUMPTIONS 46
3 EXECUTIVE SUMMARY 47
4 PREMIUM INSIGHTS 51
4.1 PESTEL 53
4.2 PORTER'S FIVE FORCES MODEL 54
5 REGULATIONS OF THE EUROPE BIOINFORMATICS MARKET 55
6 MARKET OVERVIEW 58
6.1 DRIVERS 60
6.1.1 DECREASE IN THE COST OF GENETIC SEQUENCING PER BASE 60
6.1.2 GROWING NEED FOR BIOINFORMATICS 61
6.1.3 WIDE PRODUCT PORTFOLIO OFFERED BY MAJOR PLAYERS 62
6.1.4 USE OF BIOINFORMATICS IN PERSONALIZED MEDICINE 63
6.1.5 INCREASING PUBLIC-PRIVATE SECTOR FUNDING FOR BIOINFORMATICS 63
6.2 RESTRAINTS 64
6.2.1 HIGH COST OF INSTRUMENTATION 64
6.2.2 DIFFICULTY IN CLINICAL BIOINFORMATICS ANALYSIS 64
6.2.3 CYBER SECURITY CONCERNS IN BIOINFORMATICS 65
6.3 OPPORTUNITIES 65
6.3.1 STRATEGIC INITIATIVES BY THE KEY MARKET PLAYER 65
6.3.2 PRODUCT DEVELOPMENT IN RECENT YEARS 66
6.3.3 ADVANCEMENT IN BIOINFORMATICS TECHNOLOGY 66
6.4 CHALLENGES 67
6.4.1 LACK OF SKILLED PROFESSIONALS TO PERFORM BIOINFORMATICS TECHNOLOGY 67
6.4.2 CHALLENGES TO IMPLEMENTING BIOINFORMATICS TECHNOLOGY IN THE CLINICAL LABS 67
7 EUROPE BIOINFORMATICS MARKET, BY TYPE 69
7.1 OVERVIEW 70
7.2 SERVICES 73
7.2.1 DIAGNOSTICS CONSULTATION 74
7.2.2 DATA ANALYSIS 74
7.2.2.1 STRUCTURAL 74
7.2.2.2 FUNCTIONAL 74
7.3 BIOINFORMATICS SOFTWARE 74
7.3.1 INFORMATICS INFRASTRUCTURE AND PIPELINE SETUP 76
7.3.2 SAMPLE AND EXPERIMENT MANAGEMENT 76
7.3.3 SEQUENCING DATA ANALYSIS 76
7.3.3.1 SEQUENCE ANALYSIS PLATFORM 77
7.3.3.2 SEQUENCE ALIGNMENT PLATFORM 77
7.3.3.3 SEQUENCE MANIPULATION PLATFORM 77
7.3.3.4 STRUCTURAL ANALYSIS PLATFORM 77
7.3.3.5 OTHERS 77
7.3.4 BIOLOGICAL DATA INTERPRETATION 77
7.3.5 SPECIALIZED BIOINFORMATICS APPLICATIONS 78
7.3.5.1 SINGLE CELL GENE EXPRESSION 78
7.3.5.2 GENE EXPRESSION 78
7.3.5.3 VARIANT DETECTION 78
7.3.5.4 CNV ANALYSIS 78
7.3.5.5 METAGENOMICS 79
7.3.5.6 METHYLATION 79
7.3.5.7 CHIP-SEQ 79
7.3.5.8 NON-CODING RNA EXPRESSION 79
7.3.5.9 OTHERS 79
7.3.6 OTHERS 79
7.4 KNOWLEDGE MANAGEMENT TOOLS 79
7.4.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS 80
7.4.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS 80
8 EUROPE BIOINFORMATICS MARKET, BY SECTOR 81
8.1 OVERVIEW 82
8.2 MEDICAL BIOTECHNOLOGY 85
8.3 ACADEMICS 86
8.4 ANIMAL BIOTECHNOLOGY 87
8.5 AGRICULTURAL BIOTECHNOLOGY 87
8.6 ENVIRONMENTAL BIOTECHNOLOGY 88
8.7 FORENSIC BIOTECHNOLOGY 89
8.8 OTHERS 90
9 EUROPE BIOINFORMATICS MARKET, BY APPLICATION 91
9.1 OVERVIEW 92
9.2 GENOMICS & DRUG DEVELOPMENT 95
9.2.1 SERVICES 96
9.2.2 SEQUENCING PLATFORMS 96
9.2.3 KNOWLEDGE MANAGEMENT TOOLS 96
9.2.4 GENOMICS & DRUG DEVELOPMENT BY TYPE 97
9.2.4.1 PREVENTIVE MEDICINE 97
9.2.4.2 MOLECULAR MEDICINE 97
9.2.4.3 PERSONALIZED MEDICINE 97
9.2.4.4 CHEMOINFORMATICS AND DRUG DESIGN 97
9.2.4.5 ANTIBIOTIC RESISTANCE 97
9.3 PROTEOMICS 97
9.3.1 SERVICES 99
9.3.2 SERVICES SEQUENCING PLATFORMS 99
9.3.3 KNOWLEDGE MANAGEMENT TOOLS 99
9.4 AGRICULTURAL STUDIES 99
9.4.1 SERVICES 101
9.4.2 SERVICES SEQUENCING PLATFORMS 101
9.4.3 KNOWLEDGE MANAGEMENT TOOLS 101
9.5 TRANSCRIPTOMICS 101
9.5.1 SERVICES 102
9.5.2 SERVICES SEQUENCING PLATFORMS 102
9.5.3 KNOWLEDGE MANAGEMENT TOOLS 102
9.6 METABOLOMICS 102
9.6.1 SERVICES 104
9.6.2 SERVICES SEQUENCING PLATFORMS 104
9.6.3 KNOWLEDGE MANAGEMENT TOOLS 104
9.7 EVOLUTIONARY STUDIES 104
9.7.1 SERVICES 105
9.7.2 SERVICES SEQUENCING PLATFORMS 105
9.7.3 KNOWLEDGE MANAGEMENT TOOLS 105
9.8 VETERINARY SCIENCE 105
9.8.1 SERVICES 107
9.8.2 SERVICES SEQUENCING PLATFORMS 107
9.8.3 KNOWLEDGE MANAGEMENT TOOLS 107
9.9 OTHERS 107
9.9.1 SERVICES 109
9.9.2 SERVICES SEQUENCING PLATFORMS 109
9.9.3 KNOWLEDGE MANAGEMENT TOOLS 109
10 EUROPE BIOINFORMATICS MARKET, BY PURCHASE MODE 110
10.1 OVERVIEW 111
10.2 GROUP PURCHASE 114
10.3 INDIVIDUAL PURCHASE 114
11 EUROPE BIOINFORMATICS MARKET, BY METHOD 116
11.1 OVERVIEW 117
11.2 GENOMICS 120
11.2.1 DNA 121
11.2.2 RNA 121
11.3 PROTEOMICS 121
12 EUROPE BIOINFORMATICS MARKET, BY END USER 123
12.1 OVERVIEW 124
12.2 RESEARCH AND ACADEMIC INSTITUTES 127
12.3 CLINICAL RESEARCH ORGANIZATION 127
12.4 BIOTECH AND PHARMACEUTICAL COMPANIES 128
12.5 RESEARCH LABORATORIES 129
12.6 HOSPITALS 130
12.7 OTHERS 131
13 EUROPE BIOINFORMATICS MARKET, BY REGION 132
13.1 EUROPE 133
13.1.1 GERMANY 143
13.1.2 FRANCE 149
13.1.3 U.K. 155
13.1.4 ITALY 161
13.1.5 RUSSIA 167
13.1.6 SPAIN 173
13.1.7 SWITZERLAND 179
13.1.8 NETHERLANDS 185
13.1.9 BELGIUM 191
13.1.10 TURKEY 197
13.1.11 REST OF EUROPE 203
14 EUROPE BIOINFORMATICS MARKET: COMPANY LANDSCAPE 204
14.1 COMPANY SHARE ANALYSIS: EUROPE 204
15 SWOT ANALYSIS 205
16 COMPANY PROFILE 206
16.1 BAYER AG 206
16.1.1 COMPANY SNAPSHOT 206
16.1.2 REVENUE ANALYSIS 206
16.1.3 COMPANY SHARE ANALYSIS 207
16.1.4 PRODUCT PORTFOLIO 207
16.1.5 RECENT DEVELOPMENTS 207
16.2 THERMO FISHER SCIENTIFIC INC 208
16.2.1 COMPANY SNAPSHOT 208
16.2.2 REVENUE ANALYSIS 208
16.2.3 COMPANY SHARE ANALYSIS 209
16.2.4 PRODUCT PORTFOLIO 209
16.2.5 RECENT DEVELOPMENTS 209
16.3 EUROFINS SCIENTIFIC 210
16.3.1 COMPANY SNAPSHOT 210
16.3.2 REVENUE ANALYSIS 210
16.3.3 COMPANY SHARE ANALYSIS 211
16.3.4 PRODUCT PORTFOLIO 211
16.3.5 RECENT DEVELOPMENTS 211
16.4 DASSAULT SYSTMES 212
16.4.1 COMPANY SNAPSHOT 212
16.4.2 REVENUE ANALYSIS 212
16.4.3 COMPANY SHARE ANALYSIS 213
16.4.4 PRODUCT PORTFOLIO 213
16.4.5 RECENT DEVELOPMENTS 213
16.5 AGILENT TECHNOLOGIES, INC 214
16.5.1 COMPANY SNAPSHOT 214
16.5.2 REVENUE ANALYSIS 214
16.5.3 COMPANY SHARE ANALYSIS 215
16.5.4 PRODUCT PORTFOLIO 215
16.5.5 RECENT DEVELOPMENTS 216
16.6 ASTRIDBIO TECHNOLOGIES INC. 217
16.6.1 COMPANY SNAPSHOT 217
16.6.2 PRODUCT PORTFOLIO 217
16.6.3 RECENT DEVELOPMENTS 217
16.7 BGI (A SUBSIDIARY OF BGI GROUP) 218
16.7.1 COMPANY SNAPSHOT 218
16.7.2 PRODUCT PORTFOLIO 218
16.7.3 RECENT DEVELOPMENTS 219
16.8 BIOBAM 220
16.8.1 COMPANY SNAPSHOT 220
16.8.2 PRODUCT PORTFOLIO 220
16.8.3 RECENT DEVELOPMENTS 220
16.9 DNANEXUS INC. 222
16.9.1 COMPANY SNAPSHOT 222
16.9.2 PRODUCT PORTFOLIO 222
16.9.3 RECENT DEVELOPMENTS 222
16.10 DNASTAR 223
16.10.1 COMPANY SNAPSHOT 223
16.10.2 PRODUCT PORTFOLIO 223
16.10.3 RECENT DEVELOPMENTS 223
16.11 GENOFAB, INC 224
16.11.1 COMPANY SNAPSHOT 224
16.11.2 PRODUCT PORTFOLIO 224
16.11.3 RECENT DEVELOPMENTS 224
16.12 ILLUMINA, INC 225
16.12.1 COMPANY SNAPSHOT 225
16.12.2 REVENUE ANALYSIS 225
16.12.3 PRODUCT PORTFOLIO 226
16.12.4 RECENT DEVELOPMENTS 226
16.13 PARTEK INCORPORATED 227
16.13.1 COMPANY SNAPSHOT 227
16.13.2 PRODUCT PORTFOLIO 227
16.13.3 RECENT DEVELOPMENTS 227
16.14 PERKINELMER INC. 228
16.14.1 COMPANY SNAPSHOT 228
16.14.2 PRODUCT PORTFOLIO 228
16.14.3 RECENT DEVELOPMENTS 229
16.15 QIAGEN 230
16.15.1 COMPANY SNAPSHOT 230
16.15.2 REVENUE ANALYSIS 230
16.15.3 PRODUCT PORTFOLIO 230
16.15.4 RECENT DEVELOPMENTS 231
16.16 QUEST DIAGNOSTICS INCORPORATED (2021) 232
16.16.1 COMPANY SNAPSHOT 232
16.16.2 REVENUE ANALYSIS 232
16.16.3 PRODUCT PORTFOLIO 233
16.16.4 RECENT DEVELOPMENTS 233
16.17 SEVEN BRIDGES GENOMICS 234
16.17.1 COMPANY SNAPSHOT 234
16.17.2 PRODUCT PORTFOLIO 234
16.17.3 RECENT DEVELOPMENTS 234
16.18 SOPHIA GENETICS 235
16.18.1 COMPANY SNAPSHOT 235
16.18.2 REVENUE ANALYSIS 235
16.18.3 PRODUCT PORTFOLIO 236
16.18.4 RECENT DEVELOPMENTS 236
16.19 STRAND LIFE SCIENCES 237
16.19.1 COMPANY SNAPSHOT 237
16.19.2 PRODUCT PORTFOLIO 237
16.19.3 RECENT DEVELOPMENTS 238
16.20 WATERS CORPORATION 239
16.20.1 COMPANY SNAPSHOT 239
16.20.2 PRODUCT PORTFOLIO 239
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
